SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-11-000255
Filing Date
2011-02-16
Accepted
2011-02-16 17:11:40
Documents
2
Period of Report
2011-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT adamis-8k_021011.htm 8-K 30843
2 PRESS RELEASE ex-99_1.htm EX-99.1 12300
  Complete submission text file 0001387131-11-000255.txt   44963
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-26372 | Film No.: 11618412
SIC: 2834 Pharmaceutical Preparations